Speaker articles

Take a look at what our Translation of Stem Cells to the Clinic speakers have published recently and chat with them about their work in Los Angeles.

Keynote Speakers

Hongkui Deng, Peking University, China
Direct Reprogramming of Fibroblasts via a Chemically Induced XEN-like State.

Sally Temple, Neural Stem Cell Institute, USA
Quantified F-Actin Morphology Is Predictive of Phagocytic Capacity of Stem Cell-Derived Retinal Pigment Epithelium.


Roger Barker, University of Cambridge, UK
Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New Era.

Alessandra Biffi, Harvard University, USA
Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells.

Paula Cannon, University of Southern California, USA
Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency.

Gay Crooks, University of California Los Angeles, USA 
Transcriptionally and Functionally Distinct Mesenchymal Subpopulations Are Generated from Human Pluripotent Stem Cells.

Michele de Luca, University of Modena and Reggio Emilia, Italy
Regeneration of the entire human epidermis using transgenic stem cells.

Jacques Galipeau, University of Wisconsin in Madison, USA
Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.

Steven Goldman, University of Rochester Medical Center, USA
Human iPSC Glial Mouse Chimeras Reveal Glial Contributions to Schizophrenia.

Catriona Jamieson, University of California San Diego, USA
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma.

Carl June, University of Pennsylvania, USA
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.

Tim Kieffer, The University of British Columbia, Canada
Lipid nanoparticle delivery of glucagon receptor siRNA improves glucose homeostasis in mouse models of diabetes.

Donald Kohn, University of California Los Angeles, USA
Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.

Jane Lebkowski, Regenerative Patch Technologies, USA
Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury.

Douglas Melton, Harvard University, USA 
Establishment of human pluripotent stem cell-derived pancreatic β-like cells in the mouse pancreas.

Christine Mummery, Leiden University Medical Center, The Netherlands
Inflammatory Responses and Barrier Function of Endothelial Cells Derived from Human Induced Pluripotent Stem Cells.

Chuck Murry, University of Washington, USA
Real-Time Force and Frequency Analysis of Engineered Human Heart Tissue Derived from Induced Pluripotent Stem Cells Using Magnetic Sensing.

Clive Svendsen, Cedars-Sinai Medical Center, USA
Inducible Expression of GDNF in Transplanted iPSC-Derived Neural Progenitor Cells.


Supporting Publications
Silver Sponsors